Skip to main content
. 2020 May;26(5):945–952. doi: 10.3201/eid2605.191383

Table 3. Results of seroepidemiological investigations for Zika virus according to study sites and time of sampling, Mali.

Study site and year Total no. IgG* doubtful, no. (%) IgG* positive, no. (%) VNT† positive, no. (%)
Niono 2016 65 4 (6 0.2) 4 (6.2) 2 (3.1)
Bamako 2016 129 0 (0.0) 11 (8.5) 7 (5.4)
Bamako 2013‡ 637 18 (2.8) 67 (10.5) 47 (7.4)
Kadiolo 2016 136 14 (10.3) 22 (16.2) 14 (10.3)
Bougouni 2016 127 3 (2.4) 22 (17.3) 15 (11.8)
Kita 2016 40 5 (12.5) 7 (17.5) 6 (15.0)
Bandiagara 2016 187 24 (12.8) 81 (43.3) 29 (15.5)
Diéma 2016
109
14 (12.8)
39 (35.8)
22 (20.2)
Total 1,430 82 (5.7) 253 (17.7) 142 (9.9)

*Result by Euroimmun IgG ELISA assay.
†Result by cytopathic effect-based virus neutralization test.
‡Volunteer blood donors.